Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus–associated Cryptococcal Meningitis?
Author(s) -
Justin Beardsley,
Nhat Le Thanh Hoang,
Freddie Kibengo,
Nguyen Le Nhu Tung,
Trần Quang Bình,
Le Quoc Hung,
Wirongrong Chierakul,
Guy Thwaites,
Nguyễn Văn Vĩnh Châu,
Thuong Thuong Nguyen,
Ronald B. Geskus,
Jeremy Day
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy725
Subject(s) - dexamethasone , medicine , immunology , proinflammatory cytokine , cytokine , meningitis , context (archaeology) , cerebrospinal fluid , inflammation , biology , surgery , paleontology
The CryptoDex trial showed that dexamethasone caused poorer clinical outcomes and slowed fungal clearance in human immunodeficiency virus-associated cryptococcal meningitis. We analyzed cerebrospinal fluid (CSF) cytokine concentrations from participants over the first week of treatment to investigate mechanisms of harm and test 2 hypotheses: (1) dexamethasone reduced proinflammatory cytokine concentrations, leading to poorer outcomes and (2) leukotriene A4 hydrolase (LTA4H) genotype influenced the clinical impact of dexamethasone, as observed in tuberculous meningitis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom